STRATEGY ASSET MANAGERS LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1166716 PASADENA, CA

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,519,993

+$107,141 QoQ

Shares Held

3,060

-3.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

#744

of 1,735 holders

Holding Since

Mar 2022

18 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

STRATEGY ASSET MANAGERS LLC holds $1,986,597 across 3 Biotechnology names. VRTX ranks #1 (76.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	3,060	$1,519,993
2	ARWR	Arrowhead Pharmaceuticals, Inc.	3,175	$258,794
3	ROIV	Roivant Sciences Ltd.	5,872	$207,810

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,519,993	3,060	-3.3%	Shares	Sole	2026-08-14
2026-03-31	$1,412,852	3,164	-0.8%	Shares	Sole	2026-05-12
2025-12-31	$1,446,671	3,191	+6.6%	Shares	Sole	2026-02-11
2025-09-30	$1,172,178	2,993	+1.7%	Shares	Sole	2025-11-04
2025-06-30	$1,309,778	2,942	+3.5%	Shares	Sole	2025-08-07
2025-03-31	$1,378,343	2,843	+8.8%	Shares	Sole	2025-05-09
2024-12-31	$1,052,657	2,614	-3.5%	Shares	Sole	2025-02-12
2024-09-30	$1,259,901	2,709	-40.0%	Shares	Sole	2024-11-08
2024-06-30	$2,115,802	4,514	+88.2%	Shares	Sole	2024-08-02
2024-03-31	$1,002,387	2,398	-38.3%	Shares	Sole	2024-04-25
2023-12-31	$1,581,988	3,888	-4.6%	Shares	Sole	2024-02-12
2023-09-30	$1,417,388	4,076	-9.7%	Shares	Sole	2023-11-13
2023-06-30	$1,588,521	4,514	+6.2%	Shares	Sole	2023-08-25
2023-03-31	$1,339,047	4,250	+141.2%	Shares	Sole	2023-05-02
2022-12-31	$508,830	1,762	0.0%	Shares	Sole	2023-01-13
2022-09-30	$510,169	1,762	+32.8%	Shares	Sole	2022-10-11
2022-06-30	$373,935	1,327	+11.7%	Shares	Sole	2022-07-13
2022-03-31	$310,032	1,188	—	Shares	Sole	2022-04-11
No filing history on record for this holder in this stock.